RATE (BMR) IN CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOCYTIC LEUKEMIA (ALL). C r a i g L. Kien and Bruce M. C a m i t t a ,
Medical C o l l e g e of Wisconsin, Midwest C h i l d r e n ' s Cancer C e n t e r , Milwaukee C h i l d r e n ' s H o s p i t a l , Departments o f P e d i a t r i c s and Biochemistry, Milwaukee, Using a s i n g l e dose [ly:i-glycine technique i n 15 newly diagnosed ALL p a t i e n t s , we confirmed our p r e v i o u s d a t a which showed i n c r e a s e d r a t e s of S and whole body p r o t e i n breakdown i n comp a r i s o n t o h e a l t h y c o n t r o l s (independent of p r i o r prednisone t r e a t m e n t ; 8 s o t r e a t e d ) (Cancer Res 43:5586) . I n 8 p a t i e n t s we a s s e s s e d b a s a l oxygen consumption (BMR; assume 4.83 k c a l l 1 0 ); t h e r e was a s i g n i f i c a n t l i n e a r r e g r e s s i o n between BMR ( k c a l l i ) (Y) and S ( g p r o t e i n l d ) (X): Y=3.7 X + 850 (R=0.925, p<0.001). I n d i v i d u a l v a l u e s (Y,X) f o r t h e 8 p a t i e n t s were: 835, 36; 1085, 87; 1252, 121; 1273, 134; 1614, 124; 1551, 179; 2087, 394; 2212, 308 . Excluding t h e 2 h i g h e s t v a l u e s f o r Y and X, t h e r e was s t i l l a s i g n i f i c a n t c o r r e l a t i o n (R=0.87, p<0.05), and t h e r e was a p o s i t i v e rank c o r r e l a t i o n f o r a l l 8 v a l u e s (R=0.905, p<0.01) .
There were a l s o s i g n i f i c a n t p o s i t i v e c o r r e l a t i o n s between BMR and body weight (Wt) (R10.75, p<0.05) o r age (R-0.83, p<0.05) and between S and W t o r a g e ( b o t h , R=0.86, p<0.01). M u l t i p l e r e g r e s s i o n a n a l y s i s r e v e a l e d t h a t BMR was much more h i g h l y r e l a t e d t o S t h a n t o W t .
These d a t a s u g g e s t t h a t i n c r e a s e d e n e r g y c o s t s of S a c c o u n t , a t l e a s t i n p a r t , f o r i n c r e a s e d energy requirements i n p a t i e n t s with ALL. To f u r t h e r a s s e s s our methodology ( l o s s of SCFA v i a v o l a t i l i z a t i o n ) , t h e f o l l o w i n g SCFA were added t o f e c a l homogenates i n s u f f i c i e n t q u a n t i t i e s t o r a i s e t h e ener- Fecal samples were t h e n e i t h e r a l ka l i n i z e d (Alk) (pH 7.9-8.7), a c i d i f i e d (2.8-3.2) o r l e f t unchanged (UNC) (4.0-4.8).
A f t e r s t o r a g e on d r y i c e f o r 24 h r s , t h e samples were l y o p h o l i z e d and bomb c a l o r i m e t r y performed.
There was a n approximate 20% l o s s of SCFA i n t h e Alk and UNC groups ( T a b l e ) . The p o t e n t i a l c l i n i c a l s i g n i f i c a n c e of t h i s e r r o r d u r i n g E b a l a n c e s t u d i e s w i l l be s m a l l (<5% CE i n t a k e ) unl e s s t h e a c t u a l f e c a l e x c r e t i o n of SCFA exceeds 24% o f CE int a k e .
(Support: NIH Grant HD17401) . 
WEIGHT (VLBW) INFANTS. Eun H K i m and Walter C
Boutwell. S a n t a C l a r a V a l l e v Medical Center. Deot.
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by i o n Ariagno). I n o r d e r t o m a i n t a i n t h e advantage of b r e a s t milk (EM)
f e e d i n g s i n VLBW i n f a n t s w i t h o u t c o n c u r r e n t slow growth, a p r o p r i e t a r y supplement of BM, HMF (by Mead ~o h n s o n ) has been r e c e n t l y developed. We s e l e c t e d 4 VLBW i n f a n t s f o r s t u d y and 5 f o r c o n t r o l w i t h b i r t h weights <1.6 kg (1.28 2 0.22 v 1.26 2 0.10 k g ) , a l l a p p r o p r i a t e f o r g e s t a t i o n a l age.
Study i n f a n t s r e c e i v e d banked B M w i t h HMF; c o n t r o l r e c e i v e d banked B M with t h e u s u a l d o s e s of Calcium (Ca) and Phosphorous ( P ) -60 and 30 mg/kg/day r e s p e c t i v e l y .
Both r e c e i v e d t h e same f l u i d i n t a k e (177.62 11.2 v 176.4 2 6.5 ml/kg/day) and Vitamin D (400 IU/day). Study group r e c e i v e d s i g n i f i c a n t l y g r e a t e r amounts o f p r o t e i n (3.2+0.2 v 2.0 2 0.1 gm/kg/day), Ca (165.1 + 10.4 v 118.6 2 1.5 i g / k g / d a y ) , P (85.2 + 5.3 v 56.4 2 0.8 mg/kg/day) and z i n c (1.8 + .08 v .25 + .05 mg/kg/day) compared t o t h e c o n t r o l group. Both g r o u p s t o l e r a t e d t h e f e e d i n g s t o t h e same d e g r e e w i t h o u t development of n e c r o t i z i n g e n t e r o c o l i t i s , c l i n i c a l l a b o r a t o r y o r r a d i o l o g i c a l evidence of r i c k e t t s o f p r e m a t u r i t y . I n s p i t e of t h e s m a l l number s t u d i e d , t h e s t u d y group gained weight s i g n i f i c a n t l y f a s t e r t h a n t h e c o n t r o l group (Av. 16.3 v 14.1 gm/kg/day: p( 0.032 u s i n g t h e Manning-Whitney T e s t ) .
Conclusion: VLBW i n f a n t s fed banked B M grew f a s t e r on HMF t h a n on mere supplementation w i t h Ca and P.
LONGITUDINAL STUDIES OF SOMATOMEDIN-C (SM-C) IN GROWTH-RETARDED CHILDREN WITH CROHN'S DISEASE (cD).
639 Barbara S. K i r s c h n e r and M a r j o r i e M. S u t t o n (Spon. by Lawrence M. G a r t n e r ) . P r i t z k e r Sch. of Med., Wyler C h i l d r e n ' s Hosp., Department of P e d i a t r i c s , Chicago, IL.
Our p r e v i o u s s t u d i e s demonstrated t h a t mean Sm-C l e v e l s were s i g n i f i c a n t l y lower i n growth-retarded c h i l d r e n than normallygrowing c h i l d r e n w i t h IBD ( G a s t r o e n t e r o l o g y 80:1192, 1981). We now r e p o r t l o n g i t u d i n a l d a t a i n 10 p r e v i o u s l y u n t r e a t e d growthr e t a r d e d c h i l d r e n w i t h CD, followed %=17.7 mos. P a t i e n t s : 5F and 5M, % a g e 13.2 y r s . , a l l + > 1 major h e i g h t % i l e l i n e w i t h 6 of 10 p t s . s 5 t h % i l e f o r a g e , Tanner s t a g e I o r 11. Seven of 10 p t s . r e c e i v e d d a i l y p r e d n i s o n e fi=2 mos) a f t e r t h e i n i t i a l t e s t s . Methods: Measurements of growth v e l o c i t y (cmlmo), Sm-C by RIA, c a l o r i e i n t a k e (72 h r . food d i a r i e s ) and serum albumin were obt a i n e d a t t h e o n s e t of t h e r a p y and avg. of 5 t i m e s d u r i n g t h e follow-up p e r i o d .
Sm-C l e v e l s were drawn 2 24 h r s . a f t e r t h e p r e v i o u s p r e d n i s o n e dose. R e s u l t s : Growth Vel.
Sm-C
Cal. I n t a k e C a l . I n t a k e Alb. Sm-C r o s e by 345% and preceded changes i n growth v e l o c i t y & p u b e r t a l s t a g e . Conc u r r e n t l y , c a l . i n t a k e 4 from 44% t o 102% of RDA f o r h t . a g e . 
Recent c l i n i c a l s t u d i e s have shown t h a t g r e e n f l u o r e s c e n t l i g h t i s more e f f e c t i v e i n r e d u c i n g serum b i l i r u b i n (BR) t h a n i s broad-spectrum w h i t e f l u o r e s c e n t l i g h t .
During phototherapy BR i s c o n v e r t e d t o more p o l a r i s o m e r i c s t r u c t u r e s which a r e e x c r e t e d p r i n c i p a l l y i n t h e b i l e . The most r a p i d l y formed photop r o d u c t s a r e c o n f i g u r a t i o n a l isomers, p r i n c i p a l l y Z,&-BR, which accumulate i n t h e serum and a r e slowly e x c r e t e d w i t h f i r s t -o r d e r k i n e t i c s . The o t h e r major photoproduct i s a s t r u c t u r a l isomer of BR c a l l e d lumirubin (LR) which i s formed more slowly b u t e x c r e t e d more r a p i d l y t h a n t h e c o n f i g u r a t i o n a l isomers. The r e l a t i v e c o n t r i b u t i o n o f t h e s e two photochemical r e a c t i o n s t o t h e e f f i c a c y o f phototherapy i s n o t known.
I n t h i s s t u d y , we measured t h e s t e a d y -s t a t e serum c o n c e n t r a t i o n s of t h e s e two c l a s s e s of photop r o d u c t s i n premature i n f a n t s t r e a t e d w i t h e i t h e r g r e e n o r w h i t e f l u o r e s c e n t lamps. O1) The c o n c e n t r a t i o n of Z,E-BR i n t h e serum o f i n f a n t s t r e a t e d w i t h g r e e n l i g h t was s i g n i f i c a n t l y l e s s t h a n i n i n f a n t s exposed t o w h i t e l i g h t . I n c o n t r a s t , t h e c o n c e n t r a t i o n of LR was g r e a t e r i n t h e serum of i n f a n t s t r e a t e d w i t h g r e e n l i g h t . These d a t a s u g g e s t t h e c l i n i c a l e f f i c a c y o f g r e e n p h o t o t h e r a p y may be t h e r e s u l t of i n c r e a s e d p r o d u c t i o n (and e l i m i n a t i o n ) of lumirubin. Lumirubin (LR) i s a s t a b l e photoproduct of b i l i r u b i n (BR), formed by a n e s s e n t i a l l y i r r e v e r s i b l e i n t r a m o l e c u l a r c y c l i z a t i o n r e a c t i o n . Unlike o t h e r BR photoisomers, LR i s d e t e c t e d i n b o t h u r i n e and b i l e i n i n f a n t s under p h o t o t h e r a p y (PT). C l i n i c a l s t u d i e s have suggested t h a t t h e p r o d u c t i o n and e x c r e t i o n of LR may c o n t r i b u t e t o t h e r e d u c t i o n of serum BR l e v e l s produced by PT. We t h e r e f o r e sought t o d e t e r m i n e t h e u r i n a r y LR e x c r e t i o n . We measured u r i n a r y LR c l e a r a n c e ( c l r ) r a t e i n 9 p r e t e r m i n f a n t s under PT s t u d i e d a t a mean a g e of 4 days (range 1-6).
URINARY EXCRETION OF LUMIRUBIN DURING PHOTOTHERAPY.
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Mean b i r t h w e i g h t was 1 . 8 kg ( r a n g e .7-2.9); mean g e s t a t i o n a l a g e (GA) was 3 2 wks ( r a n g e 25-37).
U r i n e and a serum sample o b t a i n e d d u r i n g t h e 24 hour c o l l e c t i o n p e r i o d were analyzed f o r BR photop r o d u c t s by HPLC. C r e a t i n i n e (Cr) c l r was measured on t h e sample.
Mean LR c l r was .16+.19 mllmin (mean2.D.) which i s equival e n t t o 854% of Cr c l r (2.623.2 ml/min). LR c l r i n c r e a s e d w i t h GA i n p a r a l l e l w i t h Cr c l r . The amount o f LR e x c r e t e d p e r 24 h o u r s was 1.451.5 mg ( r a n g e .9-4). D a i l y BR p r o d u c t i o n f a r exceeds t h e amount o f LR e x c r e t e d i n t h e u r i n e o f p r e t e r m i n f a n t s , s o t h i s cannot account f o r t h e e f f i c a c y of PT. However, were t h e c l e a r a n c e r a t e of LR t o be i n c r e a s e d t o t h a t o f Cr through pharmacologic means ( i . e . by b l o c k i n g t u b u l a r r e a b s o r p t i o n ) , u r i n a r y c l e a r a n c e of LR could become q u a n t i t a t i v e l y i m p o r t a n t . As t h e u r i n a r y e x c r e t i o n of LR does n o t account f o r t h e d e c r e a s e i n serum BR w i t h PT, t h e b i l e i s presumably t h e major s i t e of e x c r e t i o n o f BR photoproducts.
